PMX-30063: Phase Ib data

Data from the first 2 segments of a placebo-controlled, multiple-ascending dose Phase Ib trial in 56 healthy volunteers showed that up to 5 doses of 0.1-0.6 mg/kg/day PMX-30063 administered as a singl...